Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS.

Autor: Emde A; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Eitan C; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Liou LL; Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA., Libby RT; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA., Rivkin N; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Magen I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Reichenstein I; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Oppenheim H; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel., Eilam R; Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel., Silvestroni A; Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA., Alajajian B; Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA., Ben-Dov IZ; Nephrology Department, Hadassah - Hebrew University Medical Center, Jerusalem, Israel., Aebischer J; Brain Mind Institute, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Savidor A; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Levin Y; de Botton Institute for Protein Profiling, The Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, Rehovot, Israel., Sons R; Department of Cell Biology and Physiology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA., Hammond SM; Department of Cell Biology and Physiology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA., Ravits JM; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA Department of Neurosciences, UC San Diego, La Jolla, CA, USA jravits@ucsd.edu eran.hornstein@weizmann.ac.il., Möller T; Department of Neurology, School of Medicine, University of Washington, Seattle, WA, USA., Hornstein E; Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel jravits@ucsd.edu eran.hornstein@weizmann.ac.il.

Publikováno v: The EMBO journal [EMBO J] 2015 Nov 03; Vol. 34 (21), pp. 2633-51. Date of Electronic Publication: 2015 Sep 01.

Drug therapy in amyotrophic lateral sclerosis.

Autor: Distad BJ; Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA 98195, USA. jdistad@u.washington.edu, Meekins GD, Liou LL, Weiss MD, Carter GT, Miller RG

Publikováno v: Physical medicine and rehabilitation clinics of North America [Phys Med Rehabil Clin N Am] 2008 Aug; Vol. 19 (3), pp. 633-51, xi-xii.